Dong Ma

机构：Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University · ORCID：0000-0001-9557-9040

发表论文 13 篇 · 总被引 399 次 · h-index 7

代表论文

• Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study (2021 · 癌症：英文版 · 被引 207)
• Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma (2024 · Nature Communications · 被引 99)
• Integrative single-cell and spatial transcriptomic analyses identify a pathogenic cholangiocyte niche and TNFRSF12A as therapeutic target for biliary atresia (2024 · Hepatology · 被引 24)
• Mucosal-associated invariant T cells promote ductular reaction through amphiregulin in biliary atresia (2024 · EBioMedicine · 被引 22)
• PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma (2022 · Cancer Immunology Immunotherapy · 被引 19)
• Assessment of durable chemoimmunotherapy response via circulating tumor DNA in advanced esophageal squamous cell carcinoma (2022 · Thoracic Cancer · 被引 14)